Subscribe
Bobby Mukherjee, CIPA president and head of IP at BAE Systems
9 October 2025NewsEuropeSarah Speight

Bridging Brunel and AI: Why CIPA sees ‘a golden opportunity’

The promises and pitfalls of AI took centre stage at CIPA’s annual congress in Bristol this week, as Sarah Speight reports.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Unified Patent Court
'A very good decision’: Patent industry welcomes UPC in-house reps update
13 February 2025   Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v Suinno Mobile & AI Technologies Licensing.
Europe
GSK: ‘Whoever moves first has UPC advantage’
10 October 2024   Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of vaccine patents says UPC offers “strategic plank” in Europe.


Editor's picks

IP agencies vital to pharma and biotech grind to a halt
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025

Editor's picks

Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025

More features

Gilead blocks HIV drug generics for more than 10 years
Teva in-house counsel jumps to private practice
Brazil’s patent shake-up: How pharma is handling a new reality
Eli Lilly strikes AI drug discovery deal with US biotech
Why AI drug discovery has an IP problem and what can be done
Blank Rome adds more patent attorneys in ‘strategic expansion’
Simmons & Simmons patent litigator jumps ship
ITC probes on the rise, but gender parity lags behind